Novel Cancer Therapy Approach Using Synchrotron Microbeam Radiotherapy
The group of Prof. Valentin Djonov introduces a novel approach in cancer therapy employing synchrotron Microbeam Radiotherapy (MRT) as an effective enhancer of drug delivery. MRT increases vascular transpermeability, creating a "permeability window" that accelerates gold nanoparticle (AuNP) extravasation by 2.5-fold and increases the median survival time of mice bearing melanoma by 6.6-fold (1).
In a subsequent study, the group demonstrated that the permeability window is also maintained when using a clinical orthovoltage system, further supporting the potential clinical application of MRT (2).
Ongoing animal and human clinical trials are demonstrating exceptional tumor control and high normal tissue tolerance.
Fernandez-Palomo et al., Int J Radiat Oncol Biol Phys. 2025
Fazzari et al., Sci Rep. 2025